Zero Trust: Enabling the Last Mile of Biomedical AI Research

Abstract

Over 90% of all biomedical AI research is stalled due to its inability to access real world protected health information to complete the required clinical validation and valuation prior to its deployment. With AI forecasted to improve patient outcomes by 40% and costs by 50% the new paradigm of zero trust must be adopted and leveraged to avoid the existential crisis facing biomedical AI research. Join us and learn how confidential computing and blockchain meet the requirements of zero trust.

Keywords

• biomedical ai
• protected health information
• clinical validation
• zero trust
• zta
• biomedical ai research
• confidential computing
• blockchain technology
• conv2x
• bhty